The document is a profile for Image Reading Center, Inc. that lists their clinical trial experience in imaging for various therapeutic areas. It provides details on over 60 clinical trials conducted across phases I-III in areas like cardiovascular disease, diabetes, growth hormone, HIV/AIDS, neuroscience, oncology, osteoporosis, and rheumatoid arthritis. The trials involved sites in countries around the world and recruited between 30 to over 3000 subjects totaling tens of thousands of subjects. Contact information is provided for Mark Punyanitya, the Biomedical Engineer and Director.

1. Image Reading Center, Inc.
Advances in Clinical Trial Imaging
Mark Punyanitya
Biomedical Engineer, Director
Direct: 646-736-2487
Email: mark@imagereadingcenter.com
Image Reading Center, Inc.
New York, NY, USA
www.imagereadingcenter.com
CLINICAL TRIAL EXPERIENCE:
Therapeutic Areas Phase Countries Sites Subjects
Cardio-Vascular Disease III 6 20 100
Cardio-Vascular Disease III 12 30 450
Cardio-Vascular Disease II/III 3 5 80
Cardio-Vascular Disease IIII 10 20 300
Diabetes II US Only 3 125
Diabetes II US Only 3 125
Diabetes III US Only 10 300
Diabetes III US Only 15 500
Diabetes III 10 35 750
Diabetes III US Only 50 250
Gaucher Disease III 12 24 100
Gaucher Disease III 12 30 50
Growth Hormone II US Only 2 50
Growth Hormone II 2 7 75
Growth Hormone II US Only 5 100
Growth Hormone II US Only 15 200
Growth Hormone III 10 50 500
Growth Hormone III 15 30 300
HIV/AIDS III 7 7 350
HIV/AIDS III US Only 18 3000
HIV/AIDS III US Only 15 2000
HIV/AIDS III 16 80 480
HIV/AIDS III 20 40 250
Lipodystrophy III 15 15 500
Lipodystrophy III 25 25 850
Lipodystrophy III 15 20 300
Myostatin I US Only 1 100
Myostatin I US Only 3 100
Myostatin I Japan Only 1 100
Myostatin II US Only 5 32

2. Image Reading Center, Inc.
Advances in Clinical Trial Imaging
Mark Punyanitya
Biomedical Engineer, Director
Direct: 646-736-2487
Email: mark@imagereadingcenter.com
Image Reading Center, Inc.
New York, NY, USA
www.imagereadingcenter.com
CLINICAL TRIAL EXPERIENCE:
Therapeutic Areas Phase Countries Sites Subjects
Neuromuscular II US Only 3 200
Neuroscience/AD III 30 340 1100
Neuroscience/AD III 30 340 1000
Neuroscience/AD III 30 300 900
Neuroscience/AD III 30 300 800
Neuroscience/AD II Japan Only 10 30
Neuroscience/AD II Japan Only 9 30
Neuroscience/AD III 6 25 430
Neuroscience/AD III 10 40 250
Neuroscience/AD III 12 40 240
Obesity II US Only 2 75
Obesity III 7 7 400
Obesity III US Only 50 500
Obesity III US Only 20 300
Obesity III US Only 35 500
Oncology/NHL III 6 10 100
Oncology/NSCLC III 5 15 150
Oncology/Gast Ca III 6 10 100
Oncology/Malig Ascites III 12 105 250
Oncology/Breast Can II 5 10 80
Oncology/Ovarian II 4 7 50
Oncology/RCC II 10 20 80
Osteoporosis II US Only 15 800
Osteoporosis II US Only 5 100
Osteoporosis II US Only 5 100
Osteoporosis II US Only 5 250
Osteoporosis III US Only 3 500
Osteoporosis III US Only 5 300
Osteoporosis III US Only 17 300
Pediatric Bone Age II 6 10 40
Rheumatoid arthritis (RA) III 27 80 1000
Rheumatoid arthritis (RA) III 15 50 800
Rheumatoid arthritis (RA) III 25 100 1500